Synthesis and structure-activity relationship studies of substituted isoquinoline analogs as antitumor agent. 1998

S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
College of Pharmacy, Chonnam National University, Kwangju, Korea.

A number of substituted isoquinolin-1-ones, possible bioisosteres of the 5-aryl substituted 2,3-dihydroimidazo[2,1-a]isoquinolines, were synthesized and tested for their antitumor activity against five different human tumor cell lines. O-(3-hydroxypropyl) substituted compound (15) exhibited the best antitumor activity which is 3-5 times better than 5-[4'-(piperidinomethyl) phenyl]-2,3-dihydroimidazo[2,1-a]isoquinoline (1).

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
January 1993, Peptide research,
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
July 2010, Archiv der Pharmazie,
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
March 1995, Journal of medicinal chemistry,
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
July 2010, Medicinal chemistry (Shariqah (United Arab Emirates)),
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
August 1982, Gan,
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
February 2009, Bioorganic & medicinal chemistry letters,
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
March 1996, Journal of medicinal chemistry,
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
November 2007, Bioorganic & medicinal chemistry letters,
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
January 2021, Bioorganic & medicinal chemistry,
S H Cheon, and J S Park, and B H Chung, and B G Choi, and W J Cho, and S U Choi, and C O Lee
February 2014, Anti-cancer agents in medicinal chemistry,
Copied contents to your clipboard!